Diseases, Conditions, Syndromes

Mpox vaccine found to be protective by CDC

Researchers from the Mpox Emergency Response Team, Centers for Disease Control and Prevention (CDC) in Atlanta have conducted a case-control study based on data from a nationwide electronic health record database, Cosmos, ...

Diseases, Conditions, Syndromes

New rabies vaccine could reduce cost, risk

(Medical Xpress)—Researchers at the University of Georgia used a common dog disease-canine parainfluenza-to build a new vaccine to protect humans and animals from the rabies virus. Developers hope the new treatment will ...

Diseases, Conditions, Syndromes

Cholera's challenge to Haiti and the world

Debate about the public health response to Haiti's cholera epidemic continues as the crisis enters its ninth month, with some experts arguing that a vaccination campaign in Haiti would be neither feasible nor cost-effective, ...

Immunology

Computer-designed vaccine elicits potent antibodies against RSV

A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus has been designed in an international research effort. RSV is second only to malaria as a cause of infant mortality worldwide. The new vaccine ...

Diseases, Conditions, Syndromes

Updated ACIP immunization schedule released for adults

(HealthDay)—The Advisory Committee on Immunization Practices has released its updated adult immunization schedule for 2019; the schedule was published online Feb. 5 in the Annals of Internal Medicine.

page 4 from 31